摘要
目的研究探讨慢性阻塞性肺病急性加重期合并呼吸衰竭38例呼吸内科治疗的临床疗效。方法选取我院2018年1月至2019年1月收治的38例慢性阻塞性肺病急性加重期合并呼吸衰竭患者作为研究对象,随机分为研究组、对比组,并进行对比。结果两组患者临床疗效对比:两组患者经过不同治疗方案治疗后统计得知,研究组患者临床治疗显效率、有效率以及总有效率均高于对比组患者且对比具有统计学意义(P<0.05)。结论无创呼吸机联合常规抗感染化痰扩张支气管治疗方案应用在慢性阻塞性肺病急性加重期合并呼吸衰竭临床治疗中,能有效缓解患者肺部临床症状,提高患者心肺功能指标以及患后生活质量。因此,值得临床推广。
Objective To study the clinical effect of 38 patients with acute exacerbation of COPD and respiratory failure.Methods From January 2018 to January 2019,38 patients with acute exacerbation of chronic obstructive pulmonary disease(COPD)and respiratory failure were randomly divided into study group and control group.Results Comparison of the clinical efficacy of the two groups:after the treatment of different treatment schemes,the statistical results showed that the effective rate,effective rate and total effective rate of the study group were higher than those of the control group,and the comparison was statistically significant(P<0.05).Conclusion The combination of noninvasive ventilator and conventional anti infective and expectorant bronchiectasis therapy can effectively relieve the clinical symptoms of patients with acute exacerbation of chronic obstructive pulmonary disease combined with respiratory failure,and improve the indexes of cardiopulmonary function and the quality of life.Therefore,it is worthy of clinical promotion.
作者
韩秀青
HAN Xiu-qing(The People’s Hospital of Siyang County,Siyang,Jiangsu 223700)
出处
《智慧健康》
2020年第14期179-180,共2页
Smart Healthcare
